Your email has been successfully added to our mailing list.

×
-0.0552954545454547 -0.0552954545454547 -0.0552954545454547 -0.0058409090909092 -0.0248863636363636 0.0227272727272726 0.0227386363636363 0.0611363636363637
Stock impact report

Immuron Enrols First Patients in Clinical Study of IMM-529 for Treatment of Clostridium Difficile Infection (CDI)

Immuron Limited - American Depositary Shares (IMRN) 
Company Research Source: GlobeNewswire
Key Highlights: First patients enrolled in Immuron’s IMM-529 clinical study at Hadassah Medical Center in Israel Trial will treat 60 confirmed patients over 28 days to evaluate safety and efficacy of IMM-529 for the treatment of CDI CDI is one of the top superbugs challenging the healthcare industry as its germs spread easily, often requires antibiotic treatment, and leaves patients vulnerable to infections 450,000 CDI cases reported annually in the USA increasing healthcare costs from $3K to $10K per patient MELBOURNE, Australia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDQ:IMRN), an Australian microbiome biopharmaceutical company focused on developing and commercializing oral immune-therapeutics for the treatment of gut mediated diseases, today announced the enrollment of the first patients into the first-in-human IMM-529 clinical study for the treatment of Clostridium Difficile Infection (CDI). Most commonly affecting older adults after use of antibiotic m Show less Read more
Impact Snapshot
Event Time:
IMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for IMRN alerts
Opt-in for
IMRN alerts

from News Quantified
Opt-in for
IMRN alerts

from News Quantified